Form 8-K - Current report:
SEC Accession No. 0001104659-10-012508
Filing Date
2010-03-05
Accepted
2010-03-05 16:38:51
Documents
8
Period of Report
2010-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-5225_18k.htm 8-K 56969
2 EX-1.1 a10-5225_1ex1d1.htm EX-1.1 137133
3 EX-4.1 a10-5225_1ex4d1.htm EX-4.1 115922
4 EX-5.1 a10-5225_1ex5d1.htm EX-5.1 20187
5 EX-10.1 a10-5225_1ex10d1.htm EX-10.1 196806
6 EX-99.1 a10-5225_1ex99d1.htm EX-99.1 15318
7 GRAPHIC g52251ka01i001.jpg GRAPHIC 5761
8 GRAPHIC g52251mmi001.jpg GRAPHIC 5368
  Complete submission text file 0001104659-10-012508.txt   559659
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 10661192
SIC: 2836 Biological Products, (No Diagnostic Substances)